PL377110A1 - Prevention and treatment of alzheimer's disease - Google Patents
Prevention and treatment of alzheimer's diseaseInfo
- Publication number
- PL377110A1 PL377110A1 PL377110A PL37711003A PL377110A1 PL 377110 A1 PL377110 A1 PL 377110A1 PL 377110 A PL377110 A PL 377110A PL 37711003 A PL37711003 A PL 37711003A PL 377110 A1 PL377110 A1 PL 377110A1
- Authority
- PL
- Poland
- Prior art keywords
- alzheimer
- disease
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0215722A FR2848452B1 (en) | 2002-12-12 | 2002-12-12 | APPLICATION OF INTESTINAL BILIARY ACID RECAPTURE INHIBITORS FOR THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL377110A1 true PL377110A1 (en) | 2006-01-23 |
Family
ID=32338722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL377110A PL377110A1 (en) | 2002-12-12 | 2003-12-10 | Prevention and treatment of alzheimer's disease |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1572174A1 (en) |
| JP (1) | JP2006514063A (en) |
| KR (1) | KR20050084250A (en) |
| CN (1) | CN1726016A (en) |
| AR (1) | AR042354A1 (en) |
| AU (1) | AU2003296802A1 (en) |
| BR (1) | BR0317280A (en) |
| CA (1) | CA2507945A1 (en) |
| CO (1) | CO5700712A2 (en) |
| FR (1) | FR2848452B1 (en) |
| HR (1) | HRP20050534A2 (en) |
| MA (1) | MA27500A1 (en) |
| MX (1) | MXPA05005556A (en) |
| NO (1) | NO20053341L (en) |
| NZ (1) | NZ540496A (en) |
| PE (1) | PE20040770A1 (en) |
| PL (1) | PL377110A1 (en) |
| RS (1) | RS20050420A (en) |
| RU (1) | RU2005121909A (en) |
| TW (1) | TW200503707A (en) |
| WO (1) | WO2004062652A1 (en) |
| ZA (1) | ZA200504656B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| JP2007509898A (en) | 2003-11-03 | 2007-04-19 | プロビオドルグ エージー | Useful combinations for the treatment of neurological disorders |
| EP1713780B1 (en) | 2004-02-05 | 2012-01-18 | Probiodrug AG | Novel inhibitors of glutaminyl cyclase |
| EP1812007B1 (en) | 2004-11-02 | 2011-09-07 | Northwestern University | Pyridazine compounds and methods |
| CA2650711A1 (en) | 2006-04-28 | 2007-11-08 | Northwestern University | Compositions and treatments using pyridazine compounds and cholinesterase inhibitors |
| EP2937085B1 (en) * | 2007-05-22 | 2019-07-10 | Otsuka Pharmaceutical Co., Ltd. | A medicament comprising a carbostyril derivative and donezepil for treating alzheimer's disease |
| CA2852957C (en) * | 2011-10-28 | 2020-08-04 | Lumena Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease |
| US20140243281A1 (en) * | 2011-10-28 | 2014-08-28 | Lumena Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2040996A1 (en) * | 1990-05-02 | 1991-11-03 | Robert L. Albright | Composition and method for controlling cholesterol |
| JPH06502184A (en) * | 1991-02-22 | 1994-03-10 | シャピロ，ハワード ケイ． | Use of medicinal compounds for the treatment of symptoms of neurological diseases or causally related symptoms |
| EP0910351A1 (en) * | 1996-06-27 | 1999-04-28 | G.D. Searle & Co. | Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| US5985936A (en) * | 1997-12-18 | 1999-11-16 | Forbes Medi-Tech, Inc. | Method of preventing and delaying onset of Alzheimer's disease and composition therefor |
| KR20010034417A (en) * | 1998-01-28 | 2001-04-25 | 로즈 암스트롱 | Method for Treating Alzheimer's Disease |
| US6080778A (en) * | 1998-03-23 | 2000-06-27 | Children's Medical Center Corporation | Methods for decreasing beta amyloid protein |
| DE19825804C2 (en) * | 1998-06-10 | 2000-08-24 | Aventis Pharma Gmbh | 1,4-Benzothiepin-1,1-dioxide derivatives, processes for their preparation and medicaments containing these compounds |
| US6221897B1 (en) * | 1998-06-10 | 2001-04-24 | Aventis Pharma Deutschland Gmbh | Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
| DE19845405C2 (en) * | 1998-10-02 | 2000-07-13 | Aventis Pharma Gmbh | Aryl-substituted propanolamine derivatives and their use |
| AU2001233299A1 (en) * | 2000-02-04 | 2001-08-14 | Esperion Therapeutics Inc. | Methods for treating alzheimer's disease |
| US20020028826A1 (en) * | 2000-06-15 | 2002-03-07 | Robl Jeffrey A. | HMG-CoA reductase inhibitors and method |
| SE0104334D0 (en) * | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
| TWI329111B (en) * | 2002-05-24 | 2010-08-21 | X Ceptor Therapeutics Inc | Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
-
2002
- 2002-12-12 FR FR0215722A patent/FR2848452B1/en not_active Expired - Fee Related
-
2003
- 2003-12-10 PE PE2003001247A patent/PE20040770A1/en not_active Application Discontinuation
- 2003-12-10 MX MXPA05005556A patent/MXPA05005556A/en not_active Application Discontinuation
- 2003-12-10 EP EP03815109A patent/EP1572174A1/en not_active Withdrawn
- 2003-12-10 KR KR1020057010595A patent/KR20050084250A/en not_active Application Discontinuation
- 2003-12-10 BR BR0317280-5A patent/BR0317280A/en not_active IP Right Cessation
- 2003-12-10 CA CA002507945A patent/CA2507945A1/en not_active Abandoned
- 2003-12-10 CN CNA2003801059727A patent/CN1726016A/en active Pending
- 2003-12-10 PL PL377110A patent/PL377110A1/en not_active Application Discontinuation
- 2003-12-10 NZ NZ540496A patent/NZ540496A/en unknown
- 2003-12-10 WO PCT/FR2003/003654 patent/WO2004062652A1/en active Application Filing
- 2003-12-10 AU AU2003296802A patent/AU2003296802A1/en not_active Abandoned
- 2003-12-10 RU RU2005121909/15A patent/RU2005121909A/en not_active Application Discontinuation
- 2003-12-10 RS YUP-2005/0420A patent/RS20050420A/en unknown
- 2003-12-10 AR ARP030104540A patent/AR042354A1/en not_active Application Discontinuation
- 2003-12-10 JP JP2004566119A patent/JP2006514063A/en not_active Abandoned
- 2003-12-11 TW TW092134949A patent/TW200503707A/en unknown
-
2005
- 2005-06-07 ZA ZA200504656A patent/ZA200504656B/en unknown
- 2005-06-09 CO CO05056010A patent/CO5700712A2/en not_active Application Discontinuation
- 2005-06-10 MA MA28329A patent/MA27500A1/en unknown
- 2005-06-10 HR HR20050534A patent/HRP20050534A2/en not_active Application Discontinuation
- 2005-07-08 NO NO20053341A patent/NO20053341L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MA27500A1 (en) | 2005-08-01 |
| PE20040770A1 (en) | 2004-12-10 |
| CA2507945A1 (en) | 2004-07-29 |
| EP1572174A1 (en) | 2005-09-14 |
| AU2003296802A1 (en) | 2004-08-10 |
| NZ540496A (en) | 2008-04-30 |
| CO5700712A2 (en) | 2006-11-30 |
| WO2004062652A1 (en) | 2004-07-29 |
| KR20050084250A (en) | 2005-08-26 |
| NO20053341D0 (en) | 2005-07-08 |
| RS20050420A (en) | 2007-04-10 |
| JP2006514063A (en) | 2006-04-27 |
| NO20053341L (en) | 2005-09-07 |
| ZA200504656B (en) | 2006-08-30 |
| BR0317280A (en) | 2005-11-08 |
| MXPA05005556A (en) | 2005-07-26 |
| TW200503707A (en) | 2005-02-01 |
| RU2005121909A (en) | 2006-01-20 |
| HRP20050534A2 (en) | 2006-11-30 |
| FR2848452A1 (en) | 2004-06-18 |
| AR042354A1 (en) | 2005-06-15 |
| FR2848452B1 (en) | 2007-04-06 |
| CN1726016A (en) | 2006-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003290548A8 (en) | Prevention and treatment of synucleinopathic disease | |
| AU2003220096A8 (en) | Methods for alzheimer's disease treatment and cognitive enhancement | |
| AU2001249835A1 (en) | Diagnosis and treatment of alzheimer's disease | |
| IL149924A0 (en) | Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases | |
| AU2003206413A8 (en) | Substituted amino carboxamides for the treatment of alzheimer's disease | |
| SI1303272T1 (en) | Benzothiazole derivatives for the treatment of alzheimer's disease and parkinson's disease | |
| EP1817050A4 (en) | Diagnosis and treatment of alzheimer's disease | |
| AU2003231252A1 (en) | Methods and compositions for the treatment and prevention of intermittent claudication or alzheimer's disease | |
| AU2002335794A1 (en) | Allylamides useful in the treatment of alzheimer's disease | |
| AU2003268295A8 (en) | "diagnosis and treatment of infertility" | |
| NO20053341D0 (en) | Prevention and treatment of Alzheimer's disease. | |
| AU2002222108A1 (en) | Diagnosis and treatment of alzheimer's disease | |
| AU2003303141A8 (en) | Hydroxypropyl amides for the treatment of alzheimer's disease | |
| IL160018A0 (en) | Isoxazolopyridinones and use thereof in the treatment of parkinson's disease | |
| AU2003248660A8 (en) | Treatment of vascular dysfunction and alzheimer's disease | |
| IL172213A0 (en) | Compounds useful in the therapy of alzheimer's disease and formulations containing them | |
| AU5550800A (en) | Diagnosis and treatment of alzheimer's disease | |
| AU2003231279A8 (en) | Prevention and treatment of type 2 diabetes | |
| AU2003228339A8 (en) | Prevention and treatment of disease using angiogenesis-and/or tumor antigens | |
| AU2003230848A8 (en) | Methods and compositions for treating alzheimer's disease | |
| AU2003286530A8 (en) | Substituted peptides useful in the treatment of alzheimer's disease | |
| AU2003245674A8 (en) | Oral disease prevention and treatment | |
| AU2002319451A1 (en) | Therapeutic strategies for prevention and treatment of alzheimer's disease | |
| EP1669085A4 (en) | Medical agent for prevention and/or treatment of alzheimer disease | |
| GB0008162D0 (en) | Diagnosis and treatment of alzheimer's disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |